Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)

NCT00634907 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

263

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Bleeding

Interventions

GENETIC: Pharmacogenetic-based warfarin dosing
OTHER: Usual care warfarin dosing

Sponsor

Gwen McMillin